Big pharma and cancer

Saw this interesting post on immunotherapy in the Financial Times in the waiting room.

Go to ft.com/pharmaceuticals

There was also an article: « Drugmakers take an unorthodox route to cancer biosimilars »

about the NHS buying Chinese biosimilar version, which they call « copycat » of Rituximab, Trastuzumab marketed as Herceptin, Bevacizumab marketed as Avastin.

So the chief pharmacist at the Royal Marsden is achieving savings etc..

I wish we were in the business of saving lives..

I don’t like generics maybe I am shortsighted still 😃

Love

Fran x

[Hidden]

r u ok its me helen your friend who has that address.tell me

if u are not madame ps I like that song edif piaff sings she had a tragic life.

she had Algerian blood in her I like both la vie en rose and the sad one regrets

no life in pink 4 some people on this board is there mon amie?

[Hidden]

Hi Fran Biologics and biosimilars are also used for autoimmune diseases like Ra or Vasculitis. I have both and many others like me depend on biosimilars like Truxima (Rituximab) . As far as Vasculitis (and cancer) are concerned, they are life saving drugs. They have been passed by NICE, and save the NHS thousands of pounds.

[Hidden in reply to Hidden]

Thank you for the info 😊

We have Sirolimus for LAM, which I suffer from, it was a cancer drug in the first place..which is why I was interested in the article, and the outcome..

[Hidden]

Methotrexate was also a cancer drug originally but is a DMARD and not a biologic. As far as I know, they haven't created a cheaper copy of it yet.